Item 8.01 Other Events.
On
• Adult patients with transfusion-dependent anemia due to very low-, low- and intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts, who had an unsatisfactory response or are ineligible for erythropoietin-based therapy. • Adult patients with transfusion-dependent anemia associated with beta thalassemia.
A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description of Exhibit Press Release ofAcceleron Pharma Inc. and Bristol Myers Squibb 99.1 Company datedApril 30, 2020 99.2 Press Release ofAcceleron Pharma Inc. datedMay 4, 2020 Cover Page Interactive Data File (embedded within the Inline XBRL 104 document) 2
--------------------------------------------------------------------------------
© Edgar Online, source